The detection of AQP4-IgG antibodies is primarily done through a blood test using techniques like enzyme-linked immunosorbent assay (ELISA) or cell-based assays. Early and accurate detection is vital as it aids in the differential diagnosis of NMO from other demyelinating diseases such as Multiple Sclerosis (MS).
